Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

Mark J. Ratain, Tim Eisen, Walter M. Stadler, Keith T. Flaherty, Stan B. Kaye, Gary L. Rosner, Martin Gore, Apurva A. Desai, Amita Patnaik, Henry Q. Xiong, Eric Rowinsky, James L. Abbruzzese, Chenghua Xia, Ronit Simantov, Brian Schwartz, Peter J. O'Dwyer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences